Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-095397
Filing Date
2024-11-07
Accepted
2024-11-07 16:05:50
Documents
51
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0219486-10q_oramed.htm   iXBRL 10-Q 774154
2 CERTIFICATION ea021948601ex31-1_oramed.htm EX-31.1 9675
3 CERTIFICATION ea021948601ex31-2_oramed.htm EX-31.2 9572
4 CERTIFICATION ea021948601ex32-1_oramed.htm EX-32.1 4189
5 CERTIFICATION ea021948601ex32-2_oramed.htm EX-32.2 3244
  Complete submission text file 0001213900-24-095397.txt   4056135

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ormp-20240930.xsd EX-101.SCH 34912
7 XBRL CALCULATION FILE ormp-20240930_cal.xml EX-101.CAL 36471
8 XBRL DEFINITION FILE ormp-20240930_def.xml EX-101.DEF 173191
9 XBRL LABEL FILE ormp-20240930_lab.xml EX-101.LAB 353751
10 XBRL PRESENTATION FILE ormp-20240930_pre.xml EX-101.PRE 190434
53 EXTRACTED XBRL INSTANCE DOCUMENT ea0219486-10q_oramed_htm.xml XML 490276
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35813 | Film No.: 241435541
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)